Nyvepria side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Nyvepria. Common side effects include breast cancer female among females, and pancreatitis acute among males.

The phase IV clinical study is created by eHealthMe based on 48 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 01, 2023

48 people who take Nyvepria and have side effects are studied.


What is Nyvepria?

Nyvepria has active ingredients of pegfilgrastim-apgf. Currently, eHealthMe is studying from 48 Nyvepria users.

Number of Nyvepria reports submitted per year:

Nyvepria side effects.

Nyvepria side effects by time on the drug*:

< 1 month:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Acute febrile neutrophilic dermatosis (skin disease characterized by the sudden onset of fever, leukocytosis, and tender)
  3. Skin reaction

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

  1. Lymphoma (cancer that begins in immune system cells)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  4. Diarrhoea
  5. Fatigue (feeling of tiredness)
  6. Memory impairment
  7. Neoplasm malignant (cancer tumour)
  8. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  9. Obstructive airways disorder (a progressive disease that makes it hard to breathe)
  10. Death

Nyvepria side effects by gender *:

female:

  1. Breast cancer female
  2. Lymphoma (cancer that begins in immune system cells)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Acute febrile neutrophilic dermatosis (skin disease characterized by the sudden onset of fever, leukocytosis, and tender)
  5. Asthenia (weakness)
  6. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  7. Diarrhoea
  8. Fatigue (feeling of tiredness)
  9. Memory impairment
  10. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)

male:

  1. Pancreatitis acute (sudden inflammation of pancreas)
  2. Death
  3. Nausea (feeling of having an urge to vomit)
  4. B-cell lymphoma (blood cancer affecting b cells)
  5. Breast cancer
  6. Neutropenia (an abnormally low number of neutrophils)
  7. Asthenia (weakness)
  8. Neoplasm malignant (cancer tumour)
  9. Obstructive airways disorder (a progressive disease that makes it hard to breathe)

Nyvepria side effects by age (0-1 to 60+) *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Pancreatitis acute (sudden inflammation of pancreas)
  2. Nausea (feeling of having an urge to vomit)
  3. Acute febrile neutrophilic dermatosis (skin disease characterized by the sudden onset of fever, leukocytosis, and tender)
  4. Fatigue (feeling of tiredness)
  5. Memory impairment
  6. Obstructive airways disorder (a progressive disease that makes it hard to breathe)
  7. Skin reaction

50-59:

  1. Death
  2. Lymphoma (cancer that begins in immune system cells)
  3. Asthenia (weakness)
  4. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  5. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  6. Breast cancer female

60+:

  1. Death
  2. B-cell lymphoma (blood cancer affecting b cells)
  3. Breast cancer
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Asthenia (weakness)
  6. Diarrhoea
  7. Neoplasm malignant (cancer tumour)

* Approximation only. Some reports may have incomplete information.

Do you take Nyvepria?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



How the study uses the data?

The study is based on pegfilgrastim-apgf (the active ingredients of Nyvepria) and Nyvepria (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Nyvepria:

All Nyvepria side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: